State Street Corp increased its stake in shares of Central Garden & Pet Company (NASDAQ:CENTA - Free Report) by 5.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,207,738 shares of the company's stock after purchasing an additional 122,327 shares during the quarter. State Street Corp owned approximately 3.53% of Central Garden & Pet worth $85,594,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CENTA. Engineers Gate Manager LP increased its stake in Central Garden & Pet by 3.6% in the 2nd quarter. Engineers Gate Manager LP now owns 20,600 shares of the company's stock valued at $799,000 after buying an additional 717 shares during the period. Integrated Wealth Concepts LLC acquired a new stake in shares of Central Garden & Pet during the 2nd quarter valued at $44,000. Corient Private Wealth LP purchased a new position in shares of Central Garden & Pet during the 2nd quarter valued at $332,000. Odyssean LLC purchased a new position in shares of Central Garden & Pet during the 2nd quarter valued at $290,000. Finally, Headlands Technologies LLC acquired a new position in shares of Central Garden & Pet in the second quarter worth $586,000. 50.82% of the stock is owned by hedge funds and other institutional investors.
Central Garden & Pet Stock Performance
Shares of CENTA opened at $34.19 on Friday. The firm has a market cap of $2.14 billion, a price-to-earnings ratio of 12.76 and a beta of 0.59. The company's fifty day moving average is $37.16 and its 200-day moving average is $35.64. The company has a quick ratio of 2.67, a current ratio of 3.79 and a debt-to-equity ratio of 0.68. Central Garden & Pet Company has a 12 month low of $25.97 and a 12 month high of $40.79.
Central Garden & Pet (NASDAQ:CENTA - Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported $1.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.51 by $0.03. The business had revenue of $882.36 million during the quarter, compared to analyst estimates of $882.96 million. Central Garden & Pet had a net margin of 5.39% and a return on equity of 11.13%. Central Garden & Pet has set its FY 2026 guidance at 2.850- EPS. Equities analysts expect that Central Garden & Pet Company will post 2.98 EPS for the current fiscal year.
Insiders Place Their Bets
In other Central Garden & Pet news, insider John Walker, III sold 5,000 shares of the business's stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $38.50, for a total value of $192,500.00. Following the completion of the sale, the insider owned 64,679 shares of the company's stock, valued at $2,490,141.50. The trade was a 7.18% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 20.28% of the stock is currently owned by company insiders.
Analyst Ratings Changes
Several analysts recently issued reports on CENTA shares. Zacks Research lowered Central Garden & Pet from a "strong-buy" rating to a "hold" rating in a report on Tuesday, July 14th. Wall Street Zen downgraded Central Garden & Pet from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. Canaccord Genuity Group dropped their target price on Central Garden & Pet from $54.00 to $53.00 and set a "buy" rating on the stock in a research report on Wednesday, June 17th. Weiss Ratings raised Central Garden & Pet from a "buy (b-)" rating to a "buy (b)" rating in a research note on Wednesday, September 9th. Finally, JPMorgan Chase & Co. lifted their price target on Central Garden & Pet from $32.00 to $37.00 and gave the company an "underweight" rating in a report on Thursday, July 16th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $46.67.
Get Our Latest Stock Analysis on CENTA
Central Garden & Pet Profile
(
Free Report)
Central Garden & Pet Company is a marketer and manufacturer of branded products for the pet and lawn-and-garden markets. The company sells its products through retailers, distributors, e-commerce channels and other outlets, serving consumers, pet owners and gardening customers primarily in the United States.
Its pet portfolio includes products for dogs, cats, birds, fish, reptiles, small animals and other companion animals. Offerings include pet food, treats, toys, chews, bedding, habitats, aquatics products, waste-management products and animal health and wellness items.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Central Garden & Pet, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Central Garden & Pet wasn't on the list.
While Central Garden & Pet currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.